Invasive pneumococcal disease 3 years after introduction of 10-valent pneumococcal conjugate vaccine, the Netherlands
Differential B-cell memory around the 11-month booster in children vaccinated with a 10- or 13-valent pneumococcal conjugate vaccine
Response on pneumococcal vaccine in preterm infants after neutral and acidic oligosaccharides supplementation
Comparison of two-dose priming plus 9-month booster with a standard three-dose priming schedule for a ten-valent pneumococcal conjugate vaccine in Nepalese infants: a randomised, controlled, open-label, non-inferiority trial
Increased incidence of serotype-1 invasive pneumococcal disease in young female adults in The Netherlands
Pneumococcal population in the era of vaccination: changes in composition and the relation to clinical outcomes
Rijksinstituut voor Volksgezondheid
Rijksinstituut voor Volksgezondheid